<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CB597297-71EC-49CA-868E-47371DFC4207"><gtr:id>CB597297-71EC-49CA-868E-47371DFC4207</gtr:id><gtr:name>Oxford Radcliffe Hospitals NHS Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Physiology Anatomy and Genetics</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CB597297-71EC-49CA-868E-47371DFC4207"><gtr:id>CB597297-71EC-49CA-868E-47371DFC4207</gtr:id><gtr:name>Oxford Radcliffe Hospitals NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8785E853-AF63-4587-BFD8-1C96C822ADAE"><gtr:id>8785E853-AF63-4587-BFD8-1C96C822ADAE</gtr:id><gtr:firstName>Anant</gtr:firstName><gtr:otherNames>Bhikhu</gtr:otherNames><gtr:surname>Parekh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0601485"><gtr:id>AC2B1CD0-B25C-4F78-8FCB-EE4A52D30A70</gtr:id><gtr:title>Involvement of store-operated CRAC channels and mitochondrial Ca2+ dynamics in health and disease.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601485</gtr:grantReference><gtr:abstractText>The last 20 years have seen a marked rise in allergy sufferers in the U.K. Allergies come in various disguises but two particularly common ones are asthma and rhinitis/polyposis. Recent figures indicate that almost 20% of the population suffer, at some time, from rhinitis and polyposis, ailments that result in inflammation within the nose, with serious consequences on quality of life including full nasal obstruction and loss of smell. These disorders arise from a trigger-happy immune system, with the main culprit being the mast cell. Effective treatment requires detailed understanding of fundamental processes in cell biology and the application of this to mast cells may lead to new therapies for combating allergies. It is known that an increase in calcium causes the mast cell to secrete a battery of chemicals that recruit and stimulate other immune cells, blood vessels and airway muscle. If unchecked, this produces substantial local tissue damage. We seek to understand how, at a very fundamental level, calcium signals are controlled and how these contribute to mast cell activation. This work will shed new light on what happens when things go wrong with these cells and may identify novel therapeutic targets for drug therapy for allergic disorders.</gtr:abstractText><gtr:technicalSummary>A rise in intracellular Ca2+ concentration activates a disparate range of responses in virtually all animal cells. Ca2+ rises stimulate neurotransmitter release, muscle contraction, cell metabolism, cell growth and proliferation as well as cell death. Such responses can often be elicited in the same cell, raising the fundamental problem of specificity. Key to the decoding of the pleiotropic Ca2+ signal is its complex spatiotemporal organization. Distinct intracellular Ca2+ patterns allow certain effectors to be recruited, resulting in specific responses. Two key elements in shaping Ca2+signals are mitochondria and plasmalemmal store-operated Ca2+ channels. During intracellular Ca2+ signalling, mitochondria rapidly accumulate significant amounts of Ca2+ via an inner membrane ruthenium red-sensitive uniporter channel. In spite of its critical importance, virtually nothing is known about how the uniporter is controlled. Using state-of-the art methods, including patch clamp recording of the uniporter channel in mitochondria, as well as new genetically targeted probes expressed in mitochondria, we will address this issue focussing on how signalling pathways regulate this important intracellular Ca2+ channel. Store-operated CRAC channels provide a major route for raising cytoplasmic Ca2+. We have previously found that a local Ca2+ rise just below the plasma membrane in mast cells is very effective in activating long-range responses including stimulation of key intracellular enzymes as well as gene transcription. How local Ca2+ influx through CRAC channels is decoded is unclear but a new candidate sensor, the non-receptor tyrosine kinase Syk, will be investigated here using RNAi approaches combined with patch clamp recordings, measurement of cytoplasmic Ca2+, confocal microscopy and functional studies. Local Ca2+ influx through CRAC channels triggers secretion of the pro-inflammatory signal leukotriene C4 (LTC4), which is firmly linked to several allergic diseases. LTC4 can in turn activate mast cells, leading us to propose a novel positive feedback model for mast cell activation which will be developed here and extended to human mast cells. Finally, we will compare mast cell physiology from patients suffering from allergic rhinitis and nasal polyposis with suitable controls, using methods we have developed in the laboratory, including isolation of mast cells from human polyps and patch clamp slice recording techniques. This work will provide new insight into our understanding of mast cells, and how they are regulated in health and disease. The works proposed should help identify new therapeutic targets for drug therapy for these allergic disorders.</gtr:technicalSummary><gtr:fund><gtr:end>2011-01-05</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-01-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>599994</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford Radcliffe Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CRAC channels and allergic rhinitis/nasal polyposis</gtr:description><gtr:id>73DA149C-7B6B-48F5-BA52-E9176AEC88EC</gtr:id><gtr:impact>Our collaboration has resulted in a publication in the leading Allergy journal in the field (Journal of Allergy and Clinical Immunology) and has led to a new potential therapy for treating polyposis. PubMed:19895990</gtr:impact><gtr:partnerContribution>We have collaborated with an Ear-Nose-Throat consultant surgeon. His team removes tissue from patients suffering from severe allergic rhinitis or nasal polyposis, and we isolate and then study mast cell activation from the tissue. Our collaboration has resulted in a publication in the leading Allergy journal in the field (Journal of Allergy and Clinical Immunology) and has led to a new potential therapy for treating polyposis.</gtr:partnerContribution><gtr:piContribution>The ENT team removes tissue from patients suffering from severe allergic rhinitis or nasal polyposis, and we isolate and then study mast cell activation from the tissue.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit-Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>17E87769-BC6F-4D72-9C67-557D1580E802</gtr:id><gtr:impact>I delivered a lecture to 6th formers from various schools in the Oxford area on Medical research and then had question-answer type discussion with several of them. In additon, our work was presented on TV (local news) and the Radio (January 2009).

This has led to sixth formers spending 2-3 weeks each summer in my laboratory shadowing researchers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit-Oxford</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9031DC00-BEEA-4746-A2DE-5DBC62045D8D</gtr:id><gtr:impact>Talk to local 6th formers.
College/university open days.

Several have apparently applied to University to read Bio-medical sciences. This is clearly not down to me, but I gather several 'undecided' students felt the life sciences rather than the physial sciences was of mor einterest to them, following a series of talks by biomedcial scientists (myself included).</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TV and Radio</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>549ABA9C-3D8B-43CD-946F-F59C79304A72</gtr:id><gtr:impact>I was interviewed by BBC Oxford and local radio, following our discovery of a new therapy for treating allergic rhinitis and nasal polyposis.

Interest in our work has grown and we often receive letters from members of the public describing their allergies and asking for updates on our progress.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>We have found a feedforward (positive feedback) loop sustains mast cell activation, involving a dynamic interplay between CRAC channels and cysteinyl leukotrienes. we have discovered that inhibition of both CRAC channels and the leukotriene receptors suppresses human mast cell activation in vitro. These results suggest a novel therapy for controlling mast cell in vivo. We aim to directly test this in patients, in collaboration with our clinical collaborators.</gtr:description><gtr:id>2F4B0F62-53A8-4D85-9898-04CC74E989F5</gtr:id><gtr:impact>Our work has led to a collaboration with Glaxo, with the aim of developing new CRAC channel blockers.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>WO2009095719?</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>A new treatment for allergic rhinitis and nasal polyposis</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>see section 8.5</gtr:description><gtr:id>1CAB7F86-21B8-48F1-BA0F-7994D32A9B85</gtr:id><gtr:impact>see section 8.7</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>CRAC channel block</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a new model that underlies the development of nasal allergies and polyposis. We have also described a new therapy for treating these disorders.</gtr:description><gtr:id>DDF6DCA7-0BA7-4000-9C4C-A3CF9907AC42</gtr:id><gtr:impact>Publication in a leading clinical allergy-type journal.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Polyposis</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B395893B-1B84-4755-966D-738D7A705558"><gtr:id>B395893B-1B84-4755-966D-738D7A705558</gtr:id><gtr:title>Decoding of cytoplasmic Ca(2+) oscillations through the spatial signature drives gene expression.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/206a3cfddd5e3197904f846b791e689e"><gtr:id>206a3cfddd5e3197904f846b791e689e</gtr:id><gtr:otherNames>Di Capite J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F1AA0AB-91B4-4760-BB83-AB83B8FAB715"><gtr:id>7F1AA0AB-91B4-4760-BB83-AB83B8FAB715</gtr:id><gtr:title>Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f47783f0dd096f8101156df927a5120"><gtr:id>6f47783f0dd096f8101156df927a5120</gtr:id><gtr:otherNames>Ng SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2F776FAB-8629-4A8F-BCE7-AAF63FE0EEFE"><gtr:id>2F776FAB-8629-4A8F-BCE7-AAF63FE0EEFE</gtr:id><gtr:title>CRAC channels and Ca2+ signaling in mast cells.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/206a3cfddd5e3197904f846b791e689e"><gtr:id>206a3cfddd5e3197904f846b791e689e</gtr:id><gtr:otherNames>Di Capite J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/72FD57DB-98C6-44A4-A582-AFEF5C60D848"><gtr:id>72FD57DB-98C6-44A4-A582-AFEF5C60D848</gtr:id><gtr:title>Mitochondrial regulation of store-operated CRAC channels.</gtr:title><gtr:parentPublicationTitle>Cell calcium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0db233d7aec9c2f0a761f10a7651e52"><gtr:id>a0db233d7aec9c2f0a761f10a7651e52</gtr:id><gtr:otherNames>Parekh AB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0143-4160</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D8664AC8-8BC9-434A-B688-D67AD1541D57"><gtr:id>D8664AC8-8BC9-434A-B688-D67AD1541D57</gtr:id><gtr:title>Coupling of Ca(2+) microdomains to spatially and temporally distinct cellular responses by the tyrosine kinase Syk.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f47783f0dd096f8101156df927a5120"><gtr:id>6f47783f0dd096f8101156df927a5120</gtr:id><gtr:otherNames>Ng SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79DD9600-1206-49A6-A4AA-748E4464DB05"><gtr:id>79DD9600-1206-49A6-A4AA-748E4464DB05</gtr:id><gtr:title>Ca2+ -dependent inactivation of the mitochondrial Ca2+ uniporter involves proton flux through the ATP synthase.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/571b4833ba3d083178827b1b873e824c"><gtr:id>571b4833ba3d083178827b1b873e824c</gtr:id><gtr:otherNames>Moreau B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7CEF238-FB57-4030-919F-608EE61CB844"><gtr:id>F7CEF238-FB57-4030-919F-608EE61CB844</gtr:id><gtr:title>Intercellular Ca2+ wave propagation involving positive feedback between CRAC channels and cysteinyl leukotrienes.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/206a3cfddd5e3197904f846b791e689e"><gtr:id>206a3cfddd5e3197904f846b791e689e</gtr:id><gtr:otherNames>Di Capite J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5064F9C2-0A97-4741-9B52-9AE2465B69AE"><gtr:id>5064F9C2-0A97-4741-9B52-9AE2465B69AE</gtr:id><gtr:title>Targeting Ca2+ release-activated Ca2+ channel channels and leukotriene receptors provides a novel combination strategy for treating nasal polyposis.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/206a3cfddd5e3197904f846b791e689e"><gtr:id>206a3cfddd5e3197904f846b791e689e</gtr:id><gtr:otherNames>Di Capite J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601485</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>80</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>